Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-10-12

Clinical Trial Update: Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic Steatohepatitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pentoxifylline with vitamin E versus vitamin E alone for non-alcoholic steatohepatitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pentoxifylline (pentoxifylline)
  • Vitamin E (tocopherol)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Non Alcoholic Steatohepatitis | Phase 3 | Status: WITHDRAWN